RxDoctor Payments DataLook up a doctor →

Haley Tipps

Family · Tuscaloosa, ALNPI 1841766375

Payments from drug & device makers

$13,504in general payments, 2019–2025

Across 734 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novartis$1K
  • Johnson & Johnson$788
  • Merck$586
  • Daiichi Sankyo Inc.$572
  • E.r. Squibb & Sons, L.L.C.$569
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)95$1,862
Novartis80$1,228
Johnson & Johnson(2 entities)37$788
Merck36$586
Daiichi Sankyo Inc.29$572
E.r. Squibb & Sons, L.L.C.40$569
Ipsen Biopharmaceuticals, Inc27$529
Incyte Corporation19$511
Bristol Myers Squibb23$419
Pfizer32$393
Seagen Inc.17$347
Amgen15$304
Bayer14$276
AbbVie13$257
Genentech USA, Inc.12$250
Takeda Pharmaceuticals U.S.A., Inc.11$245
GSK13$241
Sanofi8$216
Eisai Inc.12$206
Pharmacyclics LLC, An Abbvie Company13$203
Regeneron Healthcare Solutions, Inc.11$203
Array Biopharma Inc12$169
Blueprint Medicines Corporation7$168
Lilly USA, LLC10$167
Exelixis Inc.7$159
Sobi, Inc7$141
Deciphera Pharmaceuticals Inc.7$138
Boehringer Ingelheim5$135
Myriad Genetic Laboratories, Inc.6$133
Stemline Therapeutics Inc.5$123
Jazz Pharmaceuticals Inc.5$112
Progenics Pharmaceuticals, Inc.6$106
Servier Pharmaceuticals LLC6$105
AVEO Pharmaceuticals, Inc.5$96
Karyopharm Therapeutics Inc.5$92
Beone Medicines USA, Inc.5$84
Gilead5$84
Rigel Pharmaceuticals, Inc.5$81
Beigene USA, Inc.5$80
Coherus Oncology, Inc.4$71
ADC Therapeutics America, Inc.4$68
EMD Serono, Inc.4$67
AMAG Pharmaceuticals, Inc.3$65
Puma Biotechnology, Inc.4$65
Myovant Sciences Inc.4$63
Acrotech Biopharma Inc.4$63
Agios Pharmaceuticals, Inc.3$54
Astellas Pharma US Inc3$54
Genmab U.S., Inc.3$53
Tolmar Pharmaceuticals, Inc.3$53
EUSA Pharma (US) LLC2$45
Sumitomo Pharma America, Inc.3$43
Mirati Therapeutics, Inc.2$38
Morphosys, US Inc.2$35
Pharmacosmos Therapeutics Inc.2$32
Immunocore Limited1$30
Novocure Inc.1$23
Sun Pharmaceutical Industries Inc.1$21
Kyowa Kirin, Inc.1$20
Tersera Therapeutics LLC1$18

How this compares

$13,504 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama →

Medicare billing

Part B allowed, 2024
$30,527
Medicare patients
260
Services billed
521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Tuscaloosa

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →